1. Home
  2. Analysis
  3. Cerezyme
  4. Pulmonary-embolism

Cerezyme and Pulmonary embolism - a phase IV clinical study of FDA data

Summary:

Pulmonary embolism is reported as a side effect among people who take Cerezyme (imiglucerase), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Fosamax, and have Asthma.

The phase IV clinical study analyzes which people have Pulmonary embolism when taking Cerezyme. It is created by eHealthMe based on reports of 6,440 people who have side effects when taking Cerezyme from the FDA, and is updated regularly.

What is Cerezyme?

Cerezyme has active ingredients of imiglucerase. eHealthMe is studying from 6,451 Cerezyme users. Check the latest studies of Cerezyme.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,333 drugs and 2,956 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

On Jul, 14, 2026

6,440 people reported to have side effects when taking Cerezyme.
Among them, 31 people (0.48%) have Pulmonary embolism.

Could Cerezyme cause Pulmonary embolism?

Among these 31 people:

How long have people been on Cerezyme when they have Pulmonary embolism? *

  • < 1 month: 40 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 20 %
  • 5 - 10 years: 20 %
  • 10+ years: 20 %

What is the gender of people who have Pulmonary embolism when taking Cerezyme? *

  • female: 51.72 %
  • male: 48.28 %

What is the age of people who have Pulmonary embolism when taking Cerezyme? *

  • 0-1: 0.0 %
  • 2-9: 3.7 %
  • 10-19: 3.7 %
  • 20-29: 14.81 %
  • 30-39: 3.7 %
  • 40-49: 7.41 %
  • 50-59: 22.22 %
  • 60+: 44.44 %

What are other drugs people take besides Cerezyme? *

  1. Neurontin: 2 people, 6.45%
  2. Avandia: 2 people, 6.45%
  3. Glyburide: 2 people, 6.45%
  4. Dexamethasone: 2 people, 6.45%
  5. Cymbalta: 2 people, 6.45%
  6. Lisinopril: 2 people, 6.45%
  7. Lovenox: 2 people, 6.45%
  8. Benadryl: 2 people, 6.45%
  9. Pepcid: 2 people, 6.45%
  10. Fosamax: 2 people, 6.45%

What are other side effects people have besides Pulmonary embolism? *

  1. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 7 people, 22.58%
  2. Back Pain: 5 people, 16.13%
  3. Fatigue (feeling of tiredness): 4 people, 12.90%
  4. Fall: 4 people, 12.90%
  5. Fever: 3 people, 9.68%
  6. Pneumonia: 3 people, 9.68%
  7. Pain: 3 people, 9.68%
  8. Death: 3 people, 9.68%
  9. Weakness: 3 people, 9.68%
  10. Bone Pain: 3 people, 9.68%

What are the existing conditions these people have? *

  1. Pain: 2 people, 6.45%
  2. Asthma: 2 people, 6.45%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.23%
  4. Pulmonary Thrombosis (scarring in the lungs): 1 person, 3.23%
  5. Multiple Myeloma (cancer of the plasma cells): 1 person, 3.23%
  6. Iron Deficiency Anaemia: 1 person, 3.23%
  7. Gastrointestinal Cancer Metastatic (gastrointestinal tract cancer spreads to other organ): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Cerezyme and have Pulmonary embolism?

- Check whether Pulmonary embolism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cerezyme:

Pulmonary embolism treatments and more:

How severe was Pulmonary embolism and when was it recovered:

Expand to all the drugs that have ingredients of imiglucerase:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cerezyme:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary embolism:

Browse all the conditions that are associated with Pulmonary embolism:

How the study uses the data?

The study uses data from the FDA. It is based on imiglucerase (the active ingredients of Cerezyme) and Cerezyme (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.